203 results on '"Lappe, Donald L"'
Search Results
2. Coronary Artery Calcium Versus Pooled Cohort Equations Score for Primary Prevention Guidance: Randomized Feasibility Trial
3. Behavioral Nudges as Patient Decision Support for Medication Adherence: The ENCOURAGE Randomized Controlled Trial
4. Abstract 12870: Absence of LDL Measurement in Secondary Prevention is Associated With Increased Subsequent Major Adverse Clinical Event (MACE) That is Only Partially Mitigated by Statin Use
5. Comparison of Three Atherosclerotic Cardiovascular Disease Risk Scores With and Without Coronary Calcium for Predicting Revascularization and Major Adverse Coronary Events in Symptomatic Patients Undergoing Positron Emission Tomography-Stress Testing
6. Safety and Efficacy of Periprocedural Heparin Plus a Short-Term Infusion of Tirofiban Versus Bivalirudin Monotherapy in Patients Who Underwent Percutaneous Coronary Intervention (from the Intermountain Heart Institute STAIR Observational Registry)
7. Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease—Real-world experience within a large integrated health care system: The IMPRES study
8. Clinical Decision Support to Efficiently Identify Patients Eligible for Advanced Heart Failure Therapies
9. Predictors of Statin Intolerance in Patients With a New Diagnosis of Atherosclerotic Cardiovascular Disease Within a Large Integrated Health Care Institution: The IMPRES Study
10. IMPACT OF ACTIVE VERSUS PASSIVE STATIN SELECTION FOR PRIMARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD): A REPORT FROM THE CORCAL VANGUARD TRIAL
11. Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System
12. Hypothyroidism as a risk factor for statin intolerance
13. Real world MRI experience with nonconditional and conditional cardiac rhythm devices after MagnaSafe
14. Relation of Routine, Periodic Fasting to Risk of Diabetes Mellitus, and Coronary Artery Disease in Patients Undergoing Coronary Angiography
15. Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population
16. The intermountain risk score predicts incremental age-specific long-term survival and life expectancy
17. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: Dependent or independent risk factors?
18. Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia
19. Relation of Vitamin D Deficiency to Cardiovascular Risk Factors, Disease Status, and Incident Events in a General Healthcare Population
20. Association of vitamin D levels with incident depression among a general cardiovascular population
21. Coronary Artery Disease Screening Using Coronary Computed Tomography Angiography—Reply
22. Relation of Bisphosphonate Therapies and Risk of Developing Atrial Fibrillation
23. Superior predictive ability for death of a basic metabolic profile risk score
24. Incremental Survival Benefit With Adherence to Standardized Heart Failure Core Measures: A Performance Evaluation Study of 2958 Patients
25. Hyperglycemia predicts mortality after CABG: postoperative hyperglycemia predicts dramatic increases in mortality after coronary artery bypass graft surgery
26. Usefulness of Routine Periodic Fasting to Lower Risk of Coronary Artery Disease in Patients Undergoing Coronary Angiography
27. Frequency of Helicobacter Pylori Seropositivity and C-Reactive Protein Increase in Atrial Fibrillation in Patients Undergoing Coronary Angiography
28. Vitamin D supplementation protects against reductions in plasma 25‐hydroxyvitamin D induced by open‐heart surgery: Assess‐d trial
29. Comparison of Effects of High (80 mg) Versus Low (20 mg) Dose of Simvastatin on C-Reactive Protein and Lipoproteins in Patients With Angiographic Evidence of Coronary Arterial Narrowing
30. Intracardiac Ultrasound for Esophageal Anatomic Assessment and Localization During Left Atrial Ablation for Atrial Fibrillation
31. Ranolazine Reduces Ventricular Tachycardia Burden and ICD Shocks in Patients with Drug-Refractory ICD Shocks
32. Atrial Fibrillation Hospitalization Is Not Increased with Short-Term Elevations in Exposure to Fine Particulate Air Pollution
33. Patients Treated with Catheter Ablation for Atrial Fibrillation Have Long-Term Rates of Death, Stroke, and Dementia Similar to Patients Without Atrial Fibrillation
34. A Strategy of Rapid Cardioversion Minimizes the Significance of Early Recurrent Atrial Tachyarrhythmias After Ablation for Atrial Fibrillation
35. Free thyroxine within the normal reference range predicts risk of atrial fibrillation
36. Warfarin Knowledge in Patients with Atrial Fibrillation: Implications for Safety, Efficacy, and Education Strategies
37. Long-Term Clinical Efficacy and Risk of Catheter Ablation for Atrial Fibrillation in Octogenarians
38. Warfarin Is Not Needed in Low-Risk Patients Following Atrial Fibrillation Ablation Procedures
39. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure
40. Temporary Esophageal Stenting Allows Healing of Esophageal Perforations Following Atrial Fibrillation Ablation Procedures
41. Less affluent area of residence and lesser-insured status predict an increased risk of death or myocardial infarction after angiographic diagnosis of coronary disease
42. Frequency of elevation of C-reactive protein in atrial fibrillation
43. Intensity Fluctuation Spectroscopy Monitors Contractile Activation in ``Resting'' Cardiac Muscle
44. Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program
45. CHA2DS2-VASc scores and Intermountain Mortality Risk Scores for the joint risk stratification of dementia among patients with atrial fibrillation
46. Free thyroxine within the normal reference range predicts risk of atrial fibrillation.
47. GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: The intermountain heart collaborative study
48. Implementation of a cardiac PET stress program: comparison of outcomes to the preceding SPECT era
49. CHA2DS2-VASc scores and Intermountain Mortality Risk Scores for the joint risk stratification of dementia among patients with atrial fibrillation.
50. Coronary Artery Plaque Volume and Obesity in Patients with Diabetes: The Factor-64 Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.